UBX - Unity Biotechnology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
1,382
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
69,080
58,907
37,373
13,707
Selling General and Administrative
19,467
16,016
9,617
5,137
Total Operating Expenses
88,547
74,923
46,990
18,844
Operating Income or Loss
-88,547
-74,923
-45,608
-18,844
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-1,248
-4,787
-103
-9,377
Income Before Tax
-86,066
-76,398
-44,656
-30,404
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-86,066
-76,398
-44,656
-30,404
Net Income
-86,066
-76,398
-44,656
-30,404
Net Income available to common shareholders
-86,066
-76,398
-44,656
-30,404
Reported EPS
Basic
-
-2.70
-1.49
-8.85
Diluted
-
-2.70
-1.49
-8.85
Weighted average shares outstanding
Basic
-
28,270
30,039
3,437
Diluted
-
28,270
30,039
3,437
EBITDA
-
-74,923
-44,304
-18,691